Cardiovascular diseases (CVDs) and their complications are among the biggest threats to Europe’s healthcare ecosystem, representing a cost of over two hundred billion euros every year for the EU. Specially Atherosclerotic cardiovascular disease (ASCVD) poses the risk of premature SSCVD to nearly 2-% of the EU’s population. According to recent studies from the Progression of Early Subclinical Atherosclerosis (PESA) cohort in Spain, healthy, middle-aged adults without a history of any CVD pose higher levels of triglycerides, making them vulnerable group. In addition to that, a portion of young adults in Europe as well as around the world is also falling victims to heart-related diseases. As alarming as these statistics are, the requirement for effective and patientcentric cardiovascular devices could not be ignored.
To help organizations and leaders select the best-of-breed vendor companies, MedTech Outlook Europe’s distinguished panel comprising CEOs, CIOs, CMOs, and analysts have reviewed and shortlisted a handful of Cardio Vascular Devices that are at the forefront of innovation and empowering Europe’s medtech arena to leverage contemporary technologies and stay abreast of the dynamic market scenarios. From manufacturing AI-based CAD diagnostic tools to providing groundbreaking noninvasive and continuous heart monitoring systems, these companies are executing the paradigm shift required to improve patient treatment and experience in Europe’s healthcare ecosystem. These companies are selected based on the innovative and user-friendly cardiovascular solutions they render to medical institutions, enterprises, and public sector entities.
We present to you MedTech Outlook Europe’s “Top 10 Cardio Vascular Devices Companies in Europe - 2022.”
